Analysis of the influencing factors of the recurrence of Cushing′s disease after transsphenoidal surgery

袁善鹏,李雪元,朱旭强,吴力新,高鹏,孔腾霄,闫东明
DOI: https://doi.org/10.3760/cma.j.cn112050-20210428-00206
2022-01-01
Abstract:Objective:To explore the influencing factors of the recurrence of Cushing′s disease (CD) after transsphenoidal surgery.Methods:A retrospective analysis was conducted on the clinical data of 164 patients with CD who were treated with microscopy or neuroendoscopic transsphenoidal surgery from May 2013 to July 2020 in the Department of Neurosurgery, the First Affiliated Hospital of Zhengzhou University and reached remission standards after surgery. We collected the data including the patient′s gender, age, smoking history, drinking history, history of hypertension, history of diabetes, history of abnormal lipid metabolism, systolic and diastolic blood pressures at admission, preoperative body mass index (BMI), imaging examination results (tumor diameter, saddle progression and invasiveness), the operation method, whether it was a second operation, and the follow-up time. The serum adrenocorticotropic hormone (ACTH), cortisol and 24 h urinary free cortisol levels on the preoperative and postoperative day one (POD1) mornings were documented. Recurrence was defined as the presence of typical clinical symptoms and hypercortisolemia during the follow-up period after postoperative remission. According to the presence or absence of recurrence, the patients were divided into recurrence group ( n=25) and non-recurrence group ( n=139). We compared the clinical data of the two groups of patients. Multivariate logistic regression analysis was used to determine the influencing factors of postoperative recurrence. Results:Compared with those in the non-recurrence group, the patients in the recurrence group had significantly higher proportion of dyslipidemia, higher preoperative BMI and preoperative morning serum ACTH level, higher proportions of macroadenoma and invasive adenomas, higher POD1 morning serum ACTH and cortisol levels, and shorter follow-up time (all P<0.05). There was no statistical significance in other indicators between the two groups of CD patients (all P>0.05). Multivariate logistic regression analysis indicated that higher preoperative BMI ( OR=1.39, 95% CI: 1.012-1.910, P=0.042), higher POD1 morning serum ACTH ( OR=1.02, 95% CI: 1.002-1.037, P=0.027) and cortisol levels ( OR=1.01, 95% CI: 1.003-1.020, P=0.010) were risk factors for postoperative recurrence. Conclusion:Patients with CD who have a higher preoperative BMI and higher POD1 morning serum ACTH and cortisol levels after transsphenoidal tumor resection seem to have a higher risk of postoperative recurrence.
What problem does this paper attempt to address?